|
Aug 14
|
Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates
|
|
Aug 14
|
Fortress Biotech: Q2 Earnings Snapshot
|
|
Aug 14
|
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
|
|
Aug 12
|
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
|
|
Aug 8
|
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 7
|
Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates
|
|
Aug 7
|
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
|
|
Aug 5
|
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
|
|
Jul 14
|
Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors
|
|
Jul 14
|
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
|
|
Jun 24
|
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
|
|
Jun 9
|
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
|
|
May 17
|
Fortress Biotech First Quarter 2025 Earnings: Beats Expectations
|
|
May 16
|
New Strong Sell Stocks for May 16th
|
|
May 15
|
Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 15
|
Fortress Biotech: Q1 Earnings Snapshot
|
|
May 15
|
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
|
|
May 14
|
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
|
|
May 13
|
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
|
|
Apr 9
|
This Fortress Biotech Insider Increased Their Holding By 26% Last Year
|